Syneos Health Appoints Michael Bonello as Chief Financial Officer

SYNHDelisted Stock  USD 42.31  0.07  0.17%   
Under 62% of Syneos Health's investor base is looking to short. The analysis of current outlook of investing in Syneos Health suggests that many traders are alarmed regarding Syneos Health's prospects. Syneos Health's investing sentiment shows overall attitude of investors towards Syneos Health.
  
MORRISVILLE, N.C., May 02, 2023 -- Syneos Health , the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael Bonello as Chief

Read at benzinga.com
benzinga news
  

Syneos Health Fundamental Analysis

We analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

Syneos Health is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Syneos Health Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Syneos Health stock to make a market-neutral strategy. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics with similar companies.

Peers

Syneos Health Related Equities

QGENQiagen NV   0.20   
0%
3.0%
MTDMettler Toledo     
1.0%
0%
MEDPMedpace Holdings   0.13   
2.0%
0%
SHCSotera Health   0.75   
13.0%
0%
IQVIQVIA Holdings   1.05   
19.0%
0%
LHLaboratory   1.07   
19.0%
0%
ICLRICON PLC   1.49   
27.0%
0%
CRLCharles River   1.78   
32.0%
0%
ACRSAclaris Therapeutics   2.48   
45.0%
0%
RDNTRadNet   3.30   
60.0%
0%
NEOGNeogen   3.57   
65.0%
0%
MYGNMyriad Genetics   5.41   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Syneos Stock

If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios